Oslo, Norway, 4 August 2022: Photocure ASA (Photocure, PHO: OSE) will announce
the second quarter and first half year 2022 financial results on Wednesday 10
August 2022 at 08:00 CEST and invites investors, analysts and the media to a
presentation at Hotel Continental, Oslo, Norway at 14:00 CEST the same day.
The investor presentation will also be streamed live and be hosted by Daniel
Schneider, CEO and Erik Dahl, CFO. The presentation will be held in English and
questions can be submitted throughout the event.
The presentation is scheduled to conclude at 14:45 CEST.
The quarterly report and presentation will be published at 08:00 CEST and will
be publicly available at www.photocure.com. The streaming event is available
through https://channel.royalcast.com/landingpage/hegnarmedia/20220810_2/
For further information, please contact:
Photocure
Erik Dahl
CFO
Tel: +47 45055000
Email: ed@photocure.com
Media and IR enquiries:
Geir Bjørlo
Corporate Communications (Norway) Tel: +47 91540000
Email: geir.bjorlo@corpcom.no
About Photocure
Photocure: The Bladder Cancer Company delivers transformative solutions to
improve the lives of bladder cancer patients. Our unique technology, making
cancer cells glow bright pink, has led to better health outcomes for patients
worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo
Stock Exchange (OSE: PHO). For more information, please visit us at
www.photocure.com, www.hexvix.com, www.cysview.com
This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.